Dodson W C, Hughes C L, Haney A F
Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC 27710.
Am J Obstet Gynecol. 1988 Aug;159(2):382-5. doi: 10.1016/s0002-9378(88)80089-9.
The use of human menopausal gonadotropins to induce superovulation in conjunction with intrauterine insemination as treatment for infertility is associated with an increased incidence of multiple gestation. Identification of clinical characteristics and/or monitored parameters of the stimulation cycles highly associated with multiple gestation would enable cancellation of these cycles. We retrospectively evaluated the clinical profiles and conception cycle characteristics of 48 infertile women undergoing the induction of superovulation and intrauterine insemination. We compared 14 of these women who conceived multiple gestations (eight twins and six triplets) with 34 who conceived singleton gestations. We found no differences between the groups in age, parity, cause or duration of infertility, duration or amount of human menopausal gonadotropin administration, serum estradiol concentrations on the day of human chorionic gonadotropin injection, number of preovulatory-sized follicles, or number of motile sperm inseminated. We conclude that neither the patients' clinical characteristics nor the parameters evaluated in monitoring human menopausal gonadotropin cycles provide information helpful in predicting which superovulation cycles will result in multiple pregnancy.
使用人绝经期促性腺激素联合宫内授精诱导超排卵治疗不孕症与多胎妊娠发生率增加有关。识别与多胎妊娠高度相关的刺激周期的临床特征和/或监测参数将有助于取消这些周期。我们回顾性评估了48例接受超排卵诱导和宫内授精的不孕妇女的临床资料和受孕周期特征。我们将其中14例怀有多胎妊娠(8例双胞胎和6例三胞胎)的妇女与34例怀有单胎妊娠的妇女进行了比较。我们发现两组在年龄、产次、不孕原因或持续时间、人绝经期促性腺激素给药的持续时间或剂量、注射人绒毛膜促性腺激素当天的血清雌二醇浓度、排卵前大小卵泡的数量或授精时活动精子的数量方面没有差异。我们得出结论,患者的临床特征或监测人绝经期促性腺激素周期时评估的参数均无法提供有助于预测哪些超排卵周期会导致多胎妊娠的信息。